About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 29 record(s)
Req # A-2020-00023
All documents, including e-mails, texts or Instant messages, memos, briefing notes, etc., regarding discussions with the Government of Canada regarding the distribution of equipment as part of the response to the coronavirus, and any documents regarding the eventual agreement of the Government with Amazon from February 1 to April 6, 2020.Organization: Canada Post
379 page(s)
August 2023
August 2023
Req # A-2022-00041
Records pertaining to COVID-19 and mandatory vaccine practice, include Canada Post employee reported COVID-19 vaccine injuries, side effects and adverse reactions, Canada Post facility cleaning and fogging, Canada Post mandatory vaccine practice, Canada Post employee deaths caused by COVID-19, Canada Post employee requests for accommodation, Mandatory vaccine practice exemptions.Organization: Canada Post
24 page(s)
August 2023
August 2023
Req # A-2023-00013
Reports, drafts, contracts, licenses, receipts, invoices, mockups, correspondence, emails, and similar documents relating to the Star Trek 50th anniversary stamps issued by Canada Post, between January 2014 and December 2017.Organization: Canada Post
131 page(s)
August 2023
August 2023
Req # A-2023-00021
Re: notes and emails from the delivery planner and the delivery plan for the Community Mailbox on the property of Russell Properties Ontario Inc, 1044 Guillaume Embrun ON K0A1W1, between January 2022 and December 2022.Organization: Canada Post
5 page(s)
August 2023
August 2023
Req # A-2023-00027
Records pertaining to the number of packages Canada Post inspectors intercepted at Canada Post's Montreal sorting station (located at 3625 Griffith St, Saint-Laurent, Quebec H4T 2C5), between 2021, 2022 and 2023 to date, including information about the quantity, type, street value of the seized items and value of contraband.Organization: Canada Post
37 page(s)
August 2023
August 2023
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
August 2023
Req # A-2023-00009
Any document that shows all seizures of illegal goods from the mail by Canada Post Corporation throughout Canada, including but not limited to the types and quantities of narcotic drugs, chemical precursors, cocaine, marijuana, acid, firearms, grenades, cigarettes, alcohol and any other goods that were seized between January 9, 2013 and March 1, 2023.Organization: Canada Post
557 page(s)
July 2023
July 2023
Req # A-2023-00024
External communications, briefings, and consultations regarding altering of the rural moratorium between September 1, 2021 to April 26, 2023, excluding any record pertaining to provincial governments and records regarding individual post offices.Organization: Canada Post
4 page(s)
July 2023
July 2023
Req # A-2022-05111
Electronic copies of the following documents. In all cases, cabinet confidences may be excluded and draft versions of documents. In all of the requests below, “draft guidelines” refers to the PMPRB Guidelines that were published for comment on October 6, 2022, or any prior drafts or versions of those 2022 Guidelines (for example, if a draft version was circulated to Health Canada for comment in September 2022, it would be part of the “draft guidelines” for the purpose of this request). • Emails or other communications from Health Canada commenting on the draft guidelines, and that were sent between July 1, 2022, and October 6, 2022. • Emails or other communications from the Board members or Board Chair commenting on the draft guidelines, and that were sent between July 1, 2022, and October 6, 2022. • Any training presentations, training manuals, or summaries of the new guidelines prepared for use by the Board Staff, Board, or other governmental departments prepared between July 1, 2022, and October 6, 2022. • Any documents with calculations of how much prices will decrease under the draft guidelines, or under alternative pricing rules, and that were prepared between January 1, 2022, and October 6, 2022 (note the change in date relative to other requests). • Any documents comparing prices or price reductions under the draft guidelines and the old PMPRB Compendium of Guidelines and Procedures. • Any documents, including legal memos, on the compliance of the draft guidelines with legal decisions about the PMPRB, including Alexion Pharmaceuticals Inc. v. Canada (Attorney General), 2021 FCA 157, Merck Canada c Canada, 2022 QCCA 240, and Innovative Medicines Canada v. Canada (Attorney General), 2020 FC 725. • Any documents which discuss how a medicine’s therapeutic class and comparator products will be established under the draft guidelines. • Any documents showing how the Board Staff arrived at the exact pricing tests discussed in paragraph 33-35 of the draft Guidelines. • Any documents which discuss how Board Staff will assess whether a price is excessive *after* an investigation has been opened. For context, the backgrounder which accompanied the draft guidelines suggested that staff will consider “the totality of the circumstances surrounding the price of the medicine, through the lens of the section 85 factors.Organization: Patented Medicine Prices Review Board Canada
197 page(s)
July 2023
July 2023
Req # A-2023-025211
With regard to the c. 2003 HDAP Report on New Patented Drug - Angiomax (http://www.pmprbcepmb.gc.ca/view.asp?ccid=583), I am looking for a copy of any supporting research, reports and calculations used to determine dosage regimens. I am specifically interested in how these quantities (in mL) were derived, the benchmark patient weight that was used (in kg) and the timeframe of the dosing.Organization: Patented Medicine Prices Review Board Canada
18 page(s)
July 2023
July 2023